FOR THE NEXT GENERATION OF PHYSICIANS
← All USMLE guides
BIOCHEMISTRY AND MOLECULAR BIOLOGY

Purine and pyrimidine metabolism: Lesch-Nyhan, ADA deficiency and drugs.

De novo and salvage synthesis, HGPRT deficiency, adenosine deaminase deficiency, orotic aciduria and drugs that block nucleotide synthesis.

Nucleotide metabolism links genetics, immunology and pharmacology. Know the enzyme and the drug that inhibits it.

Defects

  • Lesch-Nyhan syndrome: HGPRT deficiency (X-linked); hyperuricemia, gout, self-mutilation and intellectual disability.
  • ADA deficiency: accumulation of deoxyadenosine kills lymphocytes; severe combined immunodeficiency; treated with enzyme replacement or gene therapy.
  • Orotic aciduria: UMP synthase deficiency, megaloblastic anemia unresponsive to B12 or folate; treat with uridine.

Drugs

Hydroxyurea inhibits ribonucleotide reductase. Methotrexate, trimethoprim and pyrimethamine inhibit dihydrofolate reductase. 5-Fluorouracil inhibits thymidylate synthase. Mycophenolate and ribavirin inhibit IMP dehydrogenase. 6-Mercaptopurine and azathioprine block purine synthesis, and allopurinol raises their levels by blocking xanthine oxidase.

Distinction

Purine synthesis builds the ring on ribose; pyrimidine synthesis builds the ring first and then attaches ribose. Carbamoyl phosphate synthetase II (cytosol) is regulated by UTP.

Keep going in biochemistry and molecular biology

Related on USMLE WEB

Frequently asked questions

What enzyme is deficient in Lesch-Nyhan syndrome?

HGPRT.

Which drug blocks thymidylate synthase?

5-Fluorouracil.